Here are five things to know:
1. The study found the company’s porous silicone nitride promoted bone healing into the material four weeks post-implantation.
2. The porous silicone nitride utilized in the study was a cancellous-structured ceramic, which Amedica used in the center of its composite cervical implants.
3. Based on the favorable study results, Amedica re-filed an FDA application with a modified CsC-based cervical implant.
4. The CsC-based cervical implant is similar to Amedica’s ValeoC cervical implants.
5. Amedica hopes to launch its CsC technology platform in the U.S. market.
More articles on devices:
What Stryker CEO Kevin Lobo said on CNBC: 7 key quotes on healthcare, business & the future
Providence Medical Technology receives $10.5M new equity financing — 5 points
Stavros Vizirgianakis to lead Misonix as new president, CEO: 5 things to now
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
